Gritstone Bio launches public stock and warrant offering

Published on 1 Apr 2024 on Investing.com

Gritstone Bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company, has announced the...

Read the rest of the article

Start tracking your investments with Statfolio

(Bloomberg) -- Gritstone Bio Inc., a vaccine developer that once touted its ability to make a...

Bloomberg · via Yahoo Finance 11 Oct 2024

On Monday, Gritstone Bio Inc. (NASDAQ:GRTS) revealed interim Phase 2 data from the ongoing Phase ...

Benzinga · via AOL 4 Oct 2024

Gritstone bio, Inc. (NASDAQ:GRTS) Q1 2024 Earnings Call Transcript May 9, 2024 Gritstone bio, Inc...

Insider Monkey via Yahoo Finance 8 May 2024

The market expects Gritstone bio Inc. (GRTS) to deliver flat earnings compared to the year-ago qu...

Zacks via Yahoo Finance 2 May 2024

Gritstone Bio GRTS is a clinical-stage biotechnology company focused on developing vaccines targe...

Zacks via Yahoo Finance 4 Apr 2024

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on ...

Benzinga 2 Apr 2024

Tuesday, Gritstone Bio Inc (NASDAQ:GRTS) released preliminary data from the ongoing, signal-seeki...

Benzinga via Yahoo Finance 2 Apr 2024

Gritstone Bio, Inc. (NASDAQ:GRTS), a clinical-stage biotechnology company, has announced the...

Investing.com 1 Apr 2024

Investors in Gritstone bio, Inc. GRTS need to pay close attention to the stock based on moves in ...

Zacks via Yahoo Finance 18 Mar 2024

Gritstone bio Inc. (GRTS) came out with a quarterly loss of $0.26 per share versus the Zacks Cons...

Zacks via Yahoo Finance 5 Mar 2024